Denker S, Bittner A, Frick M, Kase J, et al. Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals. Leuk Lymphoma 2021 Aug 20:1-9. doi: 10.1080/10428194.2021.1964024.
PMID: 34414850